Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.

导出 OA

翻译打印收藏纠错

作者： Sanghoo,Lee ^[1] ; DongJu,Won ^[2] ; Chang-Ki,Kim ^[3] ; Jinwoo,Ahn ^[4] ; Youngkee,Lee ^[4] ; Hyeongkyun,Na ^[4] ; Yun-Tae,Kim ^[5] ; Mi-Kyeong,Lee ^[6] ; Jong Rak,Choi ^[2] ; Hwan-Sub,Lim ^[6] ; Kyoung-Ryul,Lee ^[7]

作者单位： Center for Companion Biomarker, Seoul Clinical Laboratories Healthcare Co., Ltd, Gyeonggi-do, Republic of Korea. Electronic address: sprout30@scllab.co.kr. ^[1] Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. ^[2] Center for Clinical Trial, Seoul Clinical Laboratories, Gyeonggi-do, Republic of Korea. ^[3] Center for Companion Biomarker, Seoul Clinical Laboratories Healthcare Co., Ltd, Gyeonggi-do, Republic of Korea. ^[4] Center for Technology Innovation, Seoul Clinical Laboratories, Gyeonggi-do, Republic of Korea. ^[5] Department of Molecular Diagnostics, Seoul Clinical Laboratories, Gyeonggi-do, Republic of Korea. ^[6] Center for Companion Biomarker, Seoul Clinical Laboratories Healthcare Co., Ltd, Gyeonggi-do, Republic of Korea; Department of Molecular Diagnostics, Seoul Clinical Laboratories, Gyeonggi-do, Republic of Korea; Center for Technology Innovation, Seoul Clinical Laboratories, Gyeonggi-do, Republic of Korea; Center for Clinical Trial, Seoul Clinical Laboratories, Gyeonggi-do, Republic of Korea. Electronic address: dkrlee@scllab.co.kr. ^[7]

关键词 Different geographical origins Indel mutation Nucleocapsid gene SARS-CoV-2 Viral genome sequencing